Sectoral Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $607K | Sell |
9,450
-1,430
| -13% | -$83.4K | 0.5% | 52 |
|
|
2025
Q4 | $647K | Sell |
10,880
-14,150
| -57% | -$770K | 0.52% | 53 |
|
|
2025
Q3 | $1.36M | Buy |
25,030
+1,500
| +6% | +$85.8K | 0.84% | 43 |
|
|
2025
Q2 | $1.29M | Hold |
23,530
| – | – | 0.85% | 42 |
|
|
2025
Q1 | $1.66M | Sell |
23,530
-5,870
| -20% | -$395K | 1.29% | 20 |
|
|
2024
Q4 | $1.93M | Sell |
29,400
-7,470
| -20% | -$500K | 1.29% | 23 |
|
|
2024
Q3 | $2.59M | Sell |
36,870
-4,390
| -11% | -$367K | 1.53% | 17 |
|
|
2024
Q2 | $3.4M | Sell |
41,260
-10,380
| -20% | -$864K | 1.38% | 21 |
|
|
2024
Q1 | $4.51M | Buy |
51,640
+1,570
| +3% | +$141K | 1.77% | 15 |
|
|
2023
Q4 | $4.83M | Sell |
50,070
-95,020
| -65% | -$8.41M | 2.08% | 11 |
|
|
2023
Q3 | $12.8M | Sell |
145,090
-3,358
| -2% | -$299K | 2.5% | 1 |
|
|
2023
Q2 | $12.9M | Buy |
148,448
+24,018
| +19% | +$2.26M | 2.15% | 6 |
|
|
2023
Q1 | $12.1M | Sell |
124,430
-14,350
| -10% | -$1.49M | 2.33% | 5 |
|
|
2022
Q4 | $14.4M | Sell |
138,780
-24,450
| -15% | -$2.3M | 2.78% | 4 |
|
|
2022
Q3 | $13.8M | Buy |
163,230
+21,500
| +15% | +$1.91M | 2.73% | 3 |
|
|
2022
Q2 | $11.7M | Buy |
141,730
+36,600
| +35% | +$2.91M | 2.37% | 6 |
|
|
2022
Q1 | $8.11M | Buy |
105,130
+95,000
| +938% | +$7.95M | 1.44% | 27 |
|
|
2021
Q4 | $895K | Sell |
10,130
-95,982
| -90% | -$7.92M | 0.13% | 93 |
|
|
2021
Q3 | $8.2M | Buy |
106,112
+33,390
| +46% | +$2.63M | 0.68% | 63 |
|
|
2021
Q2 | $6.07M | Sell |
72,722
-14,750
| -17% | -$1.17M | 0.49% | 77 |
|
|
2021
Q1 | $6.61M | Sell |
87,472
-9,300
| -10% | -$760K | 0.5% | 69 |
|
|
2020
Q4 | $8.49M | Sell |
96,772
-54,550
| -36% | -$4.32M | 0.6% | 61 |
|
|
2020
Q3 | $11.5M | Buy |
151,322
+19,699
| +15% | +$1.99M | 0.99% | 45 |
|
|
2020
Q2 | $16.2M | Sell |
131,623
-52,388
| -28% | -$5.21M | 1.49% | 26 |
|
|
2020
Q1 | $15.5M | Sell |
184,011
-39,890
| -18% | -$3.44M | 2.98% | 3 |
|
|
2019
Q4 | $18.9M | Buy |
223,901
+82,100
| +58% | +$6.2M | 2.82% | 6 |
|
|
2019
Q3 | $9.56M | Sell |
141,801
-11,300
| -7% | -$870K | 1.65% | 26 |
|
|
2019
Q2 | $13.1M | Buy |
153,101
+72,780
| +91% | +$6.23M | 1.57% | 23 |
|
|
2019
Q1 | $7.13M | Sell |
80,321
-11,300
| -12% | -$1.05M | 0.86% | 43 |
|
|
2018
Q4 | $7.8M | Sell |
91,621
-93,074
| -50% | -$8.85M | 1.06% | 34 |
|
|
2018
Q3 | $17.9M | Sell |
184,695
-75,810
| -29% | -$7.57M | 1.9% | 18 |
|
|
2018
Q2 | $24.5M | Sell |
260,505
-137,398
| -35% | -$12M | 2.74% | 12 |
|
|
2018
Q1 | $32.3M | Buy |
397,903
+139,400
| +54% | +$12M | 3.54% | 4 |
|
|
2017
Q4 | $23.1M | Buy |
258,503
+20,090
| +8% | +$1.75M | 2.88% | 13 |
|
|
2017
Q3 | $22.2M | Sell |
238,413
-74,969
| -24% | -$6.62M | 2.86% | 10 |
|
|
2017
Q2 | $28.5M | Sell |
313,382
-1,851
| -0.6% | -$168K | 3.11% | 13 |
|
|
2017
Q1 | $27.7M | Sell |
315,233
-176,867
| -36% | -$15.7M | 3.23% | 13 |
|
|
2016
Q4 | $40.8M | Buy |
492,100
+80,783
| +20% | +$6.95M | 4.52% | 5 |
|
|
2016
Q3 | $38.1M | Sell |
411,317
-83,519
| -17% | -$7.86M | 3.74% | 8 |
|
|
2016
Q2 | $38.5M | Sell |
494,836
-994,301
| -67% | -$84.5M | 3.98% | 8 |
|
|
2016
Q1 | $123M | Buy |
1,489,137
+129,215
| +10% | +$10.5M | 5.94% | 3 |
|
|
2015
Q4 | $142M | Buy |
1,359,922
+390,099
| +40% | +$40.7M | 6.07% | 3 |
|
|
2015
Q3 | $102M | Buy |
969,823
+3,946
| +0.4% | +$527K | 4.68% | 6 |
|
|
2015
Q2 | $132M | Sell |
965,877
-443,154
| -31% | -$54.9M | 5.51% | 4 |
|
|
2015
Q1 | $176M | Buy |
1,409,031
+155,788
| +12% | +$16.5M | 6.67% | 2 |
|
|
2014
Q4 | $113M | Sell |
1,253,243
-125,757
| -9% | -$10.5M | 5.08% | 4 |
|
|
2014
Q3 | $99.5M | Buy |
1,379,000
+210,496
| +18% | +$13.8M | 4.19% | 5 |
|
|
2014
Q2 | $72.7M | Buy |
1,168,504
+241,098
| +26% | +$14.6M | 3.08% | 11 |
|
|
2014
Q1 | $63.3M | Buy |
927,406
+213,600
| +30% | +$15.7M | 2.6% | 13 |
|
|
2013
Q4 | $50.2M | Sell |
713,806
-8,100
| -1% | -$550K | 2.17% | 22 |
|
|
2013
Q3 | $52.1M | Sell |
721,906
-1,251,158
| -63% | -$83.2M | 2.51% | 16 |
|
|
2013
Q2 | $110M | Buy |
+1,973,064
| New | +$123M | 3.25% | 12 |
|
Other funds holding BMRN
VCM
VPM
Sectoral Asset Management's BMRN Position: Q1 2026 in Review
Sectoral Asset Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 13% in Q1 2026, selling an estimated $83.4K and leaving 9,450 shares worth $607K. The position accounts for 0.5% of the portfolio, ranked #52.
Sectoral Asset Management first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $176M in Q1 2015. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Sectoral Asset Management held 9,450 shares of BioMarin Pharmaceuticals worth $607K as of Q1 2026.
- Sectoral Asset Management sold 1,430 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $83.4K.
- BioMarin Pharmaceuticals made up 0.5% of Sectoral Asset Management's portfolio in Q1 2026, its #52 holding.
- Sectoral Asset Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Sectoral Asset Management's BioMarin Pharmaceuticals position peaked at $176M in Q1 2015.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.